Liposidomycin A

Liposidomycin A exhibits antibacterial properties, though its activity is relatively weak. It demonstrates significant inhibitory effects on mycobacteria, with a minimum inhibitory concentration (MIC) of 0.16 μg/mL. Additionally, Liposidomycin A inhibits glycopeptide biosynthesis, effectively suppressing Escherichia coli glycopeptide biosynthesis with an IC50 of 0.03 μg/mL.

C(O[C@H]1[C@H](OS(=O)(=O)O)[C@H](O)[C@@H](CN)O1)([C@H]2O[C@H]([C@H](O)[C@@H]2O)N3C(=O)NC(=O)C=C3)C4N(C)CC(OC(CC(OC(CC(CC(O)=O)C)=O)CCCC=CCC=CCCCCC)=O)C(C(O)=O)N(C)C4=O